Top Line:

Metformin, a drug commonly prescribed for diabetes, has attracted significant attention for its potential anti-aging properties. While it may extend lifespan in some organisms, the main benefit lies in its ability to improve health span by reducing the risk of age-related diseases and promoting overall metabolic health.

Why It Matters:

As people live longer, the challenge of maintaining good health into old age becomes increasingly important. Metformin offers a potential intervention not just for managing diabetes but also for enhancing longevity and improving quality of life by reducing the risks associated with aging. Understanding its mechanisms and effects can profoundly affect public health and aging-related research.

Key Takeaways:

• Longevity Pathways in Humans and Animals: Metformin affects key metabolic pathways like sirtuin 1 (SIRT1) and the mammalian target of rapamycin mTOR, which is associated with longevity. It mimics the benefits of calorie restriction, improving insulin sensitivity and reducing oxidative stress in humans and animals 1, 4, 7, 10.
• Heterogeneous Effects in Model Organisms: Metformin has mixed results in animal studies, showing benefits mainly when started early in life. Some studies have observed lifespan extension, but it is not universal across all models 2, 4, 5, 7.
• Mechanisms of Action: Metformin improves metabolic health by activating AMP-activated protein kinase (AMPK), reducing oxidative stress, and promoting mitochondrial function, which helps delay the aging processes 4, 5, 6, 7.
• Healthspan Over Lifespan: Metformin consistently improves health span by lowering the risk of age-related diseases such as cardiovascular disease and cancer, even if it doesn’t always extend lifespan 3, 8, 9, 10.
• Human Cellular Studies: In vitro studies show that metformin delays cellular aging by enhancing antioxidant pathways and improving stress responses, offering insight into its potential anti-aging effects 6.

Introduction

Metformin, one of the most widely used drugs for type 2 diabetes, has garnered interest for its potential anti-aging effects. Beyond its glucose-lowering properties, research has shown that metformin may influence longevity pathways, leading scientists to explore whether it can extend lifespan and improve overall health in aging individuals. This article reviews current evidence from animal models, human studies, and cellular research to examine the effects metformin can have on longevity.

Longevity Pathways in Humans and Animals

Metformin affects several critical pathways known to be linked with aging and longevity. For example, it increases the expression of SIRT1, a protein involved in regulating stress responses and metabolism, which has been linked to increased lifespan in animals. Additionally, metformin reduces activity in the mTOR pathway, a critical regulator of cell growth and aging. Overactive mTOR signaling has been associated with accelerated aging and cancer. By reducing mTOR activity, metformin mimics some of the benefits of calorie restriction, which is known to extend lifespan in various species.

In prediabetic humans, metformin has been shown to improve metabolic markers, such as insulin sensitivity and plasma glucose levels, while also modifying longevity-associated pathways. In animal studies, particularly in mice, metformin has been observed to mimic the beneficial effects of calorie restriction by enhancing mitochondrial function and reducing oxidative damage.

Mixed Results in Model Organisms

Studies on model organisms, such as mice and Caenorhabditis elegans, reveal mixed results regarding metformin’s ability to extend lifespan. Some studies show significant lifespan extension, especially when treatment begins early in life, whereas others fail to find a clear effect. In C. elegans, for example, metformin extends lifespan by promoting mitohormesis, a process where mild oxidative stress triggers adaptive responses that ultimately protect the organism from more severe stress. However, these effects appear context-dependent, with factors like the organism’s diet, genetic background, and environmental conditions influencing outcomes.

Mechanisms of Action

Metformin’s potential anti-aging properties are linked to its ability to activate AMPK, a crucial energy sensor that regulates cellular metabolism. AMPK activation by metformin improves glucose uptake, increases fatty acid oxidation, and enhances mitochondrial function. More importantly, AMPK promotes autophagy, the process by which cells remove damaged components and regenerate, vital for maintaining cellular health and longevity.

Another critical mechanism is the reduction of oxidative stress. Aging is closely tied to oxidative damage caused by reactive oxygen species (ROS). Metformin reduces ROS production by improving mitochondrial efficiency and upregulating antioxidant defense pathways, such as the Nrf2-GPx7 pathway. Nrf2 is a transcription factor that regulates the expression of antioxidant genes, while GPx7 (glutathione peroxidase 7) is an enzyme that helps neutralize harmful ROS. This protects cells from damage and delays the aging process at a cellular level.

Healthspan vs. Lifespan

While metformin does not consistently extend lifespan across all studies, it appears to have a more reliable effect on improving healthspan—the period of life spent in good health. By reducing the incidence of age-related diseases such as diabetes, cardiovascular disease, and cancer, metformin helps individuals live healthier lives even if their overall lifespan isn’t significantly extended. In animal models, metformin-treated mice showed a delay in the onset of diseases typically associated with aging, indicating that the drug’s primary benefit may be enhancing quality of life rather than merely prolonging it.

Human Cellular Studies

Metformin has been shown to delay cellular aging in human cellular models by enhancing the body’s antioxidant defenses. It upregulates pathways that help cells resist oxidative stress and delays the process of cellular senescence, a state where cells stop dividing and accumulate damage. These findings suggest that metformin may help maintain cellular health, potentially reducing the effects of aging at the molecular level.

Conclusion:

While the evidence for metformin’s ability to extend lifespan is mixed, its effects on health span are more consistently positive. Metformin enhances metabolic health, reduces oxidative stress, and delays the onset of age-related diseases, contributing to longer periods of healthy living. Its influence on key longevity pathways, including SIRT1, mTOR, and AMPK, supports its potential as an anti-aging intervention. However, further research, particularly long-term human clinical trials, is needed to determine whether metformin can reliably extend human lifespan.

References:

1. Kreutzenberg, S., Ceolotto, G., Cattelan, A., Pagnin, E., Mazzucato, M., Garagnani, P., Borelli, V., Bacalini, M., Franceschi, C., Fadini, G., & Avogaro, A. (2015). Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 25 7, 686-93. https://doi.org/10.1016/j.numecd.2015.03.007.
2. Parish, A., & Swindell, W. (2022). Metformin has heterogeneous effects on model organism lifespans and is beneficial when started at an early age in Caenorhabditis elegans: A systematic review and meta‐analysis. Aging Cell, 21. https://doi.org/10.1111/acel.13733.
3. Mohammed, I., Hollenberg, M., Ding, H., & Triggle, C. (2021). A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.718942.
4. Martín-Montalvo, A., Mercken, E., Mitchell, S., Palacios, H., Mote, P., Scheibye-Knudsen, M., Gomes, A., Ward, T., Minor, R., Blouin, M., Schwab, M., Pollak, M., Zhang, Y., Yu, Y., Becker, K., Bohr, V., Ingram, D., Sinclair, D., Wolf, N., Spindler, S., Bernier, M., & Cabo, R. (2013). Metformin improves healthspan and lifespan in mice. Nature communications, 4, 2192 - 2192. https://doi.org/10.1038/ncomms3192.
5. Haes, W., Frooninckx, L., Assche, R., Smolders, A., Depuydt, G., Billen, J., Braeckman, B., Schoofs, L., & Temmerman, L. (2014). Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proceedings of the National Academy of Sciences, 111, E2501 - E2509. https://doi.org/10.1073/pnas.1321776111.
6. Fang, J., Yang, J., Wu, X., Zhang, G., Li, T., Wang, X., Zhang, H., Wang, C., Liu, G., & Wang, L. (2018). Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7. Aging Cell, 17. https://doi.org/10.1111/acel.12765.
7. Onken, B., & Driscoll, M. (2010). Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS ONE, 5. https://doi.org/10.1371/journal.pone.0008758.
8. Anisimov, V., Berstein, L., Egormin, P., Piskunova, T., Popovich, I., Zabezhinski, M., Tyndyk, M., Yurova, M., Kovalenko, I., Poroshina, T., & Semenchenko, A. (2008). Metformin slows down aging and extends life span of female SHR mice. Cell Cycle, 7, 2769 - 2773. https://doi.org/10.4161/cc.7.17.6625.
9. Barzilai, N., Crandall, J., Kritchevsky, S., & Espeland, M. (2016). Metformin as a Tool to Target Aging. Cell metabolism, 23 6, 1060-1065. https://doi.org/10.1016/j.cmet.2016.05.011.
10. Sunjaya, A., & Sunjaya, A. (2020). Targeting ageing and preventing organ degeneration with metformin.. Diabetes & metabolism. https://doi.org/10.1016/j.diabet.2020.09.009.

Jon Esposito PhD, CSCS, CISSN, USAW